LOSS OF BAP1 CONFERS RESISTANCE TO FERROPTOSIS AND PROMOTES CHOLANGIOCARCINOMA DEVELOPMENT

被引：0
|
作者：
Classon, Peyton [1 ]
Jaramillo, Sophia [1 ]
Carlson, Danielle [1 ]
Yan, Irene [2 ]
Ilyas, Sumera [1 ]
Smoot, Rory [1 ]
Gores, Gregory [1 ]
Patel, Tushar
Povero, Davide [1 ]
机构：
[1] Mayo Clin Rochester, Rochester, MN USA
[2] Mayo Clin Florida, Jacksonville, FL USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1830
引用
收藏
页数：1
相关论文
共 50 条
  • [31] LOSS OF BAP1 FUNCTION LEADS TO TRAIL SENSITIVITY IN MESOTHELIOMA
    Kumar, N.
    Kolluri, K. K.
    Alifrangis, C.
    Ishii, Y.
    Price, S.
    Michaut, M.
    Williams, S.
    Barthorpe, S.
    Lightfoot, H.
    Busacca, S.
    Sharkey, A.
    Yuan, Z.
    Sage, E. K.
    Vallath, S.
    Le Quesne, J.
    Tice, D. A.
    Alrifai, D.
    von Karstedt, S.
    Montinaro, A.
    Guppy, N.
    Waller, D. A.
    Nakas, A.
    Good, R.
    Holmes, A.
    Walczak, H.
    Fennell, D. A.
    Garnett, M.
    Iorio, F.
    Wessels, L.
    McDermott, U.
    Janes, S. M.
    THORAX, 2018, 73 : A1 - A1
  • [32] Functional analysis of BAP1, de-ubiquitination enzyme, in intrahepatic cholangiocarcinoma
    Ishii, Kentaro
    Ishida, Masaharu
    Ohnuma, Shinobu
    Kudoh, Katsuyoshi
    Motoi, Fuyuhiko
    Naitoh, Takeshi
    Selaru, Florin
    Unno, Michiaki
    CANCER RESEARCH, 2017, 77
  • [33] Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
    Ladanyi, Marc
    Vega, Francisco Sanchez
    Zauderer, Marjorie
    GENOME MEDICINE, 2019, 11 (1)
  • [34] A novel role for BAP1 in development and tumor suppression
    Owens, Dawn A.
    Kuznetsov, Jeffim N.
    Kurtenbach, Stefan
    Aguero, Tristan
    King, Mary Lou
    Harbour, J. William
    CANCER RESEARCH, 2019, 79 (13)
  • [35] Multiomics profiling of BAP1 loss in uveal melanoma.
    Baqai, Usman
    Purwin, Timothy
    Bechtel, Nelisa
    Chua, Vivian
    Han, Anna
    Aplin, Andrew E.
    CANCER RESEARCH, 2021, 81 (13)
  • [36] Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
    Marc Ladanyi
    Francisco Sanchez Vega
    Marjorie Zauderer
    Genome Medicine, 11
  • [37] Loss of BAP1 expression is very rare in breast carcinoma
    Chui, Jeanie
    Singh, Arjun
    Gill, Anthony J.
    PATHOLOGY, 2017, 49 (05) : 557 - 560
  • [38] Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation
    Dey, Anwesha
    Seshasayee, Dhaya
    Noubade, Rajkumar
    French, Dorothy M.
    Liu, Jinfeng
    Chaurushiya, Mira S.
    Kirkpatrick, Donald S.
    Pham, Victoria C.
    Lill, Jennie R.
    Bakalarski, Corey E.
    Wu, Jiansheng
    Phu, Lilian
    Katavolos, Paula
    LaFave, Lindsay M.
    Abdel-Wahab, Omar
    Modrusan, Zora
    Seshagiri, Somasekar
    Dong, Ken
    Lin, Zhonghua
    Balazs, Mercedesz
    Suriben, Rowena
    Newton, Kim
    Hymowitz, Sarah
    Garcia-Manero, Guillermo
    Martin, Flavius
    Levine, Ross L.
    Dixit, Vishva M.
    SCIENCE, 2012, 337 (6101) : 1541 - 1546
  • [39] Absence of Nuclear BAP1 Protein Expression Is Highly Sensitive for Loss-of-Function BAP1 Genomic Alterations in Malignant Mesothelioma
    Pal, Prodipto
    Dong, Fei
    Vivero, Marina
    LABORATORY INVESTIGATION, 2016, 96 : 478A - 478A
  • [40] Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development
    Figueiredo, Carlos R.
    Kalirai, Helen
    Sacco, Joseph J.
    Azevedo, Ricardo A.
    Duckworth, Andrew
    Slupsky, Joseph R.
    Coulson, Judy M.
    Coupland, Sarah E.
    JOURNAL OF PATHOLOGY, 2020, 250 (04): : 420 - 439
12345